A lawsuit accusing Medtronic (NYSE:MDT) of fraud and negligence in promoting off-label use of its Infuse bone-growth protein creeps closer to trial following a California judge’s decision to dismiss the medical device giant’s request for dismissal.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
NuVasive vows to fight Medtronic’s latest patent blitz
NuVasive Inc. (NSDQ:NUVA) is prepared to go another round in the long-running spinal patent battle against Medtronic (NYSE:MDT).
Medtronic sues NuVasive – again
Medtronic (NYSE:MDT) is taking its long-running patent beef with NuVasive Inc. (NSDQ:NUVA) to Indiana with a new lawsuit claiming infringement of spinal implant patents.
First DePuy ASR lawsuit settles before trial
The 1st lawsuit in what’s likely to be a long series filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over its ASR metal-on-metal hip implant settled ahead of trial, according to court documents.
The case, Rundle et al vs. DePuy Orthopaedics, was slated to go before a jury Dec. 3 in Nevada’s 8th Judicial District Court.
Smith & Nephew demands $1M from rival for non-compete violations
Orthopedic titan Smith & Nephew (FTSE:SN, NYSE:SNN) sued rival device maker Exact Surgical for $1 million dollars for hiring a former S&M rep to sell orthopedic devices in Texas.
U.K. regulators want more data on Smith & Nephew’s Exogen bone healing system
British orthopedic devices maker Smith & Nephew (FTSE:SN, NYSE:SNN) will need to provide more information on its Exogen bone-healing system before getting the green light for use in all fractures, U.K. regulators said.
Legal: More DePuy hip lawsuits gather under Texas litigation
Four more patient lawsuits alleging injuries related to Pinnacle metal-on-metal hip implants made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics will join an ongoing multidistrict litigation.
FDA: Johnson & Johnson’ new DePuy Synthes Spine division touts 1st win
Johnson & Johnson’s (NYSE:JNJ) newly formed DePuy Synthes Spine division came out of the gates swinging, announcing its 1st regulatory win less than a month after closing the books on the $19.7 billion merger.
M&A: Smith & Nephew looks to make moves
Smith & Nephew (FTSE:SN, NYSE:SNN) is on the hunt for buyout candidates, according to CEO Olivier Bohuon, ranging from a "bolt-on acquisition at $10 million to something much more significant."
FDA OKs edible sensor “pill” under new device category | MassDevice.com On Call
MASSDEVICE ON CALL — The FDA handed Proteus Digital Health clearance for its novel ingestible sensor, passing the product through a new medical device category.
The sensor is swallowed in a pill and powered through contact with stomach fluids. The device communicates wirelessly with a patch on the skin, which collects metrics such as heart rate, body position and activity.
Legal news: NuVasive goes after ex-sales reps now with Lanx
NuVasive Inc. (NSDQ:NUVA) opened another front in its ongoing war with rival Lanx Inc., accusing 3 former sales reps of defecting to Lanx and taking trade secrets with them.